Phase II study of first-line paclitaxel (PTX) with panitumumab (P) in patients with metastatic or recurrent head and neck cancer: TTCC-2009-03 study

Date 26 September 2015
Event European Cancer Congress 2015
Session Head and Neck Cancer
Topics Head and Neck Cancers
Presenter Adansa Klain, J.C.